Boothbay Fund Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Buy
+19,198
New +$2.68M 0.03% 566
2019
Q4
Sell
-2,654
Closed -$204K 962
2019
Q3
$204K Buy
+2,654
New +$232K 0.02% 652

Other funds holding RGEN

Boothbay Fund Management's RGEN Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Repligen (RGEN) in Q1 2026: 19,198 shares worth $2.26M. The stake represents 0.03% of the portfolio and ranks #566 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in RGEN as recently as Q3 2019.

Boothbay Fund Management first reported a position in RGEN in Q3 2019 and has held it in 2 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Boothbay Fund Management held 19,198 shares of Repligen worth $2.26M as of Q1 2026.
  • Repligen was a new Boothbay Fund Management position in Q1 2026.
  • Repligen made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #566 holding.
  • Boothbay Fund Management first reported a position in Repligen in Q3 2019 and has held it in 2 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.